HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takanori Matsui Selected Research

Ascites

1/2009Paclitaxel chemotherapy for the treatment of gastric cancer.
6/2004[A case report of unresectable gastric cancer that responded to 5-FU plus paclitaxel (FT) therapy].
11/2003[Effective use of combination chemotherapy with paclitaxel and 5-fluorouracil in a case of non-resectable advanced gastric cancer].
10/2003[A case of advanced gastric cancer treated with weekly paclitaxel with measurement of paclitaxel concentrations in blood and ascites].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takanori Matsui Research Topics

Disease

28Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 07/2009
27Atherosclerosis
03/2023 - 01/2006
25Neoplasms (Cancer)
09/2023 - 10/2004
24Diabetic Retinopathy (Retinopathy, Diabetic)
01/2018 - 05/2005
23Stomach Neoplasms (Stomach Cancer)
09/2020 - 10/2003
22Cardiovascular Diseases (Cardiovascular Disease)
03/2023 - 01/2006
19Inflammation (Inflammations)
08/2023 - 01/2006
17Diabetic Angiopathies (Diabetic Angiopathy)
10/2016 - 11/2005
14Insulin Resistance
12/2023 - 08/2007
13Type 2 Diabetes Mellitus (MODY)
03/2021 - 03/2007
11Neoplasm Metastasis (Metastasis)
01/2021 - 11/2008
11Hyperglycemia
07/2020 - 02/2006
10Body Weight (Weight, Body)
01/2024 - 01/2013
10Colorectal Neoplasms (Colorectal Cancer)
09/2023 - 04/2006
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014 - 06/2006
6Fibrosis (Cirrhosis)
11/2023 - 02/2011
6Vascular System Injuries
01/2018 - 06/2007
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2024 - 02/2006
5Hemorrhage
03/2023 - 02/2022
5Chronic Renal Insufficiency
10/2020 - 11/2009
4Essential Hypertension
08/2023 - 11/2005
4Thrombosis (Thrombus)
08/2021 - 03/2008
4Melanoma (Melanoma, Malignant)
01/2021 - 04/2014
4Albuminuria
10/2020 - 11/2016
4Hypertension (High Blood Pressure)
07/2020 - 01/2006
4Colonic Neoplasms (Colon Cancer)
12/2019 - 10/2004
4Proteinuria
08/2012 - 05/2009
4Ascites
01/2009 - 10/2003
3Atherosclerotic Plaque (Atheroma)
03/2023 - 10/2018
3Hepatocellular Carcinoma (Hepatoma)
09/2021 - 05/2006
3Adenocarcinoma
11/2020 - 07/2007
3Hypoglycemia (Reactive Hypoglycemia)
02/2020 - 12/2012
3Obesity
02/2020 - 05/2011
3Pathologic Neovascularization
01/2018 - 05/2006
3Dehydration (Water Stress)
10/2015 - 10/2007

Drug/Important Bio-Agent (IBA)

87Advanced Glycation End ProductsIBA
03/2023 - 08/2005
42pigment epithelium-derived factorIBA
08/2021 - 05/2005
19Proteins (Proteins, Gene)FDA Link
12/2023 - 10/2006
16Receptor for Advanced Glycation End ProductsIBA
03/2023 - 11/2005
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021 - 11/2005
13Biomarkers (Surrogate Marker)IBA
05/2022 - 03/2007
11Nucleotide AptamersIBA
01/2021 - 07/2007
10Paclitaxel (Taxol)FDA LinkGeneric
01/2016 - 10/2003
9NADPH Oxidases (NAD(P)H oxidase)IBA
08/2021 - 06/2007
8Glucose (Dextrose)FDA LinkGeneric
03/2021 - 08/2009
8Blood Glucose (Blood Sugar)IBA
01/2021 - 03/2010
7CreatinineIBA
01/2021 - 09/2009
7Telmisartan (Micardis)FDA Link
01/2020 - 11/2005
7Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2020 - 06/2007
7Insulin (Novolin)FDA Link
01/2020 - 09/2009
7Angiotensin IIIBA
06/2019 - 08/2005
7Glycoproteins (Glycoprotein)IBA
03/2011 - 07/2007
6LigandsIBA
03/2023 - 11/2009
6Cisplatin (Platino)FDA LinkGeneric
09/2020 - 11/2005
6Retinaldehyde (Retinal)IBA
09/2014 - 07/2006
5Angiotensin II Type 1 Receptor BlockersIBA
08/2023 - 01/2008
5GlyceraldehydeIBA
12/2021 - 12/2012
5DNA (Deoxyribonucleic Acid)IBA
11/2020 - 07/2007
5Glucagon-Like Peptide 1 (GLP 1)IBA
01/2013 - 01/2010
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2009 - 02/2007
4Sodium-Glucose Transport ProteinsIBA
01/2024 - 11/2016
4Antihypertensive Agents (Antihypertensives)IBA
08/2023 - 06/2019
4oxidized low density lipoproteinIBA
03/2023 - 05/2007
4C-Reactive ProteinIBA
03/2023 - 05/2006
4Uric Acid (Urate)IBA
01/2019 - 06/2006
4AlbuminsIBA
01/2018 - 01/2010
4Reactive Oxygen Species (Oxygen Radicals)IBA
02/2013 - 06/2007
4N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2013 - 01/2008
4Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2011 - 01/2008
4PPAR gammaIBA
07/2010 - 01/2008
4Nifedipine (Adalat)FDA LinkGeneric
07/2010 - 01/2006
4Fluorouracil (Carac)FDA LinkGeneric
11/2006 - 11/2003
3MicroRNAs (MicroRNA)IBA
09/2023 - 05/2019
3olmesartanIBA
08/2023 - 01/2008
3ApolipoproteinsIBA
03/2023 - 10/2007
3Peptides (Polypeptides)IBA
03/2021 - 03/2010
3HMGB1 Protein (HMG1)IBA
01/2021 - 12/2009
3Docetaxel (Taxotere)FDA Link
09/2020 - 01/2012
3Messenger RNA (mRNA)IBA
07/2020 - 09/2007
3Streptozocin (Streptozotocin)FDA Link
07/2020 - 01/2013
3Dipeptidyl-Peptidase IV InhibitorsIBA
07/2020 - 12/2011
3AdiponectinIBA
01/2020 - 02/2008
3HDL CholesterolIBA
01/2020 - 09/2009
3sulforaphaneIBA
01/2018 - 09/2014
3Cell Surface ReceptorsIBA
01/2018 - 02/2015
3Capecitabine (Xeloda)FDA Link
01/2018 - 07/2016
3AntibodiesIBA
01/2018 - 09/2007
3S-1 plus cisplatinIBA
01/2018 - 01/2012
3Nuclear Antigens (Extractable Nuclear Antigens)IBA
11/2017 - 02/2014
3XELOXIBA
01/2017 - 07/2016
3Monoclonal AntibodiesIBA
01/2017 - 11/2006
3LipidsIBA
05/2015 - 11/2009
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2015 - 07/2006
3Anti-Inflammatory Agents (Anti-Inflammatories)IBA
07/2010 - 01/2008

Therapy/Procedure

16Therapeutics
03/2023 - 06/2004
7Neoadjuvant Therapy
09/2020 - 01/2012
7Drug Therapy (Chemotherapy)
04/2015 - 11/2003
6Adjuvant Chemotherapy
01/2019 - 11/2006
3Gastrectomy
01/2019 - 01/2016
3Light Coagulation
03/2011 - 03/2007